Mobile

A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared with Ropinirole Immediate R...

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-000184-25

A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared with Ropinirole Immediate Release (IR) Tablets in Subjects with Restless Legs Syndrome (RLS)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the superior tolerability of ropinirole XR compared to ropinirole IR in adult subjects with RLS requiring evening and night-time coverage of RLS symptoms.

Critère d'inclusion

  • Restless Legs Syndrome (RLS)

Liens